The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-2-Cyano-3-cyclopropyl-3-hydroxy-N-[4-(4-trifluoromethyl-phenoxy)-phenyl]-acrylamide ID: ALA341877
Max Phase: Preclinical
Molecular Formula: C20H15F3N2O3
Molecular Weight: 388.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#C/C(C(=O)Nc1ccc(Oc2ccc(C(F)(F)F)cc2)cc1)=C(/O)C1CC1
Standard InChI: InChI=1S/C20H15F3N2O3/c21-20(22,23)13-3-7-15(8-4-13)28-16-9-5-14(6-10-16)25-19(27)17(11-24)18(26)12-1-2-12/h3-10,12,26H,1-2H2,(H,25,27)/b18-17-
Standard InChI Key: QYJIVQRUEXKOKH-ZCXUNETKSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
1.5250 -9.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1167 -8.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7292 -10.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3792 -2.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1375 -10.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7375 -9.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9167 -8.0417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0583 -8.9625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5417 -11.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3542 -10.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5917 -3.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9042 -9.0667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1750 -1.7167 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5792 -2.7292 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.1875 -2.3167 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.2417 -5.7167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3875 -3.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0042 -3.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5042 -7.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5042 -10.4375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0250 -4.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6625 -6.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 -4.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2167 -4.7000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2917 -6.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3000 -7.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8750 -6.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8792 -7.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 11 1 0
5 3 1 0
6 1 1 0
7 2 1 0
8 6 3 0
9 5 1 0
10 5 1 0
11 18 1 0
12 2 2 0
13 4 1 0
14 4 1 0
15 4 1 0
16 22 1 0
17 23 1 0
18 24 2 0
19 7 1 0
20 3 1 0
21 16 1 0
22 28 1 0
23 21 2 0
24 21 1 0
25 19 2 0
26 19 1 0
27 25 1 0
28 26 2 0
10 9 1 0
22 27 2 0
17 11 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 388.35Molecular Weight (Monoisotopic): 388.1035AlogP: 5.18#Rotatable Bonds: 5Polar Surface Area: 82.35Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 5.58CX Basic pKa: ┄CX LogP: 4.06CX LogD: 2.25Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.42Np Likeness Score: -1.26
References 1. Kuo EA, Hambleton PT, Kay DP, Evans PL, Matharu SS, Little E, McDowall N, Jones CB, Hedgecock CJ, Yea CM, Chan AW, Hairsine PW, Ager IR, Tully WR, Williamson RA, Westwood R.. (1996) Synthesis, structure-activity relationships, and pharmacokinetic properties of dihydroorotate dehydrogenase inhibitors: 2-cyano-3-cyclopropyl-3-hydroxy-N-[3'-methyl-4'-(trifluoromethyl)phenyl ] propenamide and related compounds., 39 (23): [PMID:8917650 ] [10.1021/jm9604437 ]